AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04999696 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: radical hysterectomy
Description: To compare disease-free survival and overall survival of patients with early stage cervical cancer undergoing total laparoscopic radical hysterectomy versus total abdominal radical hysterectomy
Study NCT04783194 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone+ Bupivacaine
Description: Dexamethasone plus bupivacaine in bilateral trans-incisional paravertebral block in lumbar spine surgery.
Study NCT04783194 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Bupivacaine in bilateral trans-incisional paravertebral block in lumbar spine surgery.
Study NCT05566847 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Accountable Population Manager outreach
Description: Patients will be referred to an Accountable Population Manager (APM) for proactive outreach, including supporting medication adherence and educational and overall support for T2D management. An APM is a non-physician clinician (for example, a clinical pharmacist) supporting diabetes management.
Study NCT04059562 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Combination of Lonsurf® and Irinotecan
Description: Trifluridine/Tipiracil (Lonsurf®) and Irinotecan~* Trifluridine/Tipiracil will be administered at a dose of 25 mg/m2 / dose twice daily on days 1-5 followed by a 9-days recovery period from day 6 trough day 14 of each 14-days treatment cycle.~* Irinotecan will be administered at the same time as Trifluridine/Tipiracil (Lonsurf®) on day 1 of each cycle at a dose of 180 mg/m2 / dose.
Study NCT04948671 — intervention group
Intervention type: OTHER
Intervention: there will be no intervention, this is an observational study
Description: this is an observational study
Study NCT06554639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Administered at a dose of 2.5 mg or 5 mg dependent on HRT dosing regimen via oral tablets.
Study NCT06554639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Description: Administered at a dose of 0.05 mg per HRT dosing regimen via oral tablets.
Study NCT06554639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diltiazem hydrocholoride
Description: Administered at a dose of 240 mg per dosing regimen via oral capsule (extended-release).
Study NCT06641414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lisaftoclax (APG-2575)
Description: QD, oral administration.
Study NCT06155682 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation (active)
Description: non-invasive active repetitive stimulation applied to the scalp surface
Study NCT06155682 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation (sham)
Description: non-invasive active repetitive stimulation applied to the scalp surface
Study NCT05776576 — intervention group
Intervention type: BEHAVIORAL
Intervention: Evaluation
Description: Within the scope of the evaluation, first of all, physical activity levels of children and adolescents with physical disabilities, barriers that prevent them from participating in physical activity, and motivators that can increase their participation will be determined, accompanied by an interactive roundtable meeting. Afterwards, posture analyzes of children and adolescents with special needs with physical disabilities will be performed by physiotherapists.
Study NCT05776576 — intervention group
Intervention type: BEHAVIORAL
Intervention: Education
Description: In the education part, interactive informative seminars titled Physical Activity in Individuals with Special Needs will be given and after the objective posture assessments, postural disorders of children and adolescents with special needs will be determined and accordingly, posture and ergonomics training will be given to the participants individually.
Study NCT05776576 — intervention group
Intervention type: OTHER
Intervention: Experimentation
Description: In the experimentation part, group exercises, dance therapy programs and technology-supported exercise educations with various technological equipment will be implemented in the company of physiotherapists, taking into account the posture assessments.
Study NCT06641414 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine Injection
Description: QD, hypodermic or intravenous injection.
Study NCT06641414 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azacitidine Injection
Description: QD, hypodermic or intravenous injection.
Study NCT06641414 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: QD, oral administration.
Study NCT06086639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online Occupational Therapy Group Training
Description: In this study, a 4-week online occupational therapy group training was conducted by an occupational therapist specialized in the field of nutrition. The content of the training, which takes place one hour a week, is given below; Session-1 Defining the problem Understanding the causes Oral motor structures and anomalies Discussion Session-2 Feedback sharing The relationship between feeding and sensory integration Recognizing the symptoms of sensory integration Disorders Strategies for sensory integration disorders Discussion Session-3 Feedback sharing Parent behaviors and attitudes Behavioral strategies for feeding problems Discussion Session-4 Feedback sharing Self-compassion and self-regulation Cope with stress Discussion Review of outputs
Study NCT06206473 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mEEG assessment
Description: mEEG assessment (V1) will be performed at the patient's bed within 72 hours of the diagnosis of delirium. The mEEG recording, which lasts approximately 2 hours, will be performed by one of the investigators with expertise in electrophysiological acquisition. This non-invasive assessment consists of placing an EEG net on the scalp of the participants and earphones through which the auditory stimuli will be delivered.
Study NCT04461106 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Social Marketing Campaign
Description: aims to raise awareness about the benefits of eggs - 'why eggs': increasing the value of eggs from a consumer perspective and encourage consumption of eggs by children (\<5yrs) and pregnant/lactating women
Study NCT05916196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-Fluoroestradiol
Description: 18F-FES PET/CT
Study NCT06557694 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Data collected included maternal demographics, medication during pregnancy, the gestational week when COVID-19 was diagnosed, antenatal diseases occurring after COVID-19 detection during pregnancy, intrauterine growth retardation (IUGR), small for gestational age (SGA), fetal distress, intrauterine fetal demise (IUFD), intrapartum complications, gestational age (GA) at delivery, mode of delivery, postpartum hemorrhage (PPH), admission to the maternal ICU, birth weight, admission to the NICU, and the indication for NICU hospitalization Pregnancy outcomes included mode of delivery, gestational age at delivery, pre-eclampsia, and postpartum hemorrhage (defined as an estimated blood loss of 1,000 mL or greater).
Study NCT05507944 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FeNO measurement
Description: Diurnal measurements before work and at 3 hours after work start.
Study NCT05008913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]Adavosertib
Description: Patients will receive a single administration of \[14C\]Adavosertib as an oral solution on Day 1.
Study NCT05483816 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: VR+TENS
Description: The subjects will receive a therapy that combines electrical pleasant stimulation of the nerves, synchronised with event in virtual reality
Study NCT05483816 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: VR+TENS
Description: The subjects will receive a therapy that combines electrical pleasant stimulation of the nerves, synchronised with event in virtual reality
Study NCT04831216 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Type 2 Diabetes Appropriate Food Boxes + Diabetes Education
Description: All participants will be assigned to a single intervention arm. The intervention includes weekly delivery of type 2 diabetes-appropriate food boxes that include diabetes self-management education materials.
Study NCT04687241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Almonertinib
Description: The initial dose of Almonertinib 110 mg daily can be reduced to 55 mg daily under specific conditions.
Study NCT04687241 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Almonertinib
Description: Placebo Almonertinib
Study NCT05642169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT
Description: The training sessions will have a frequency of 3 times per week (Monday, Wednesday and Friday) and the duration will be between 39 to 54 minutes, depending on the training week.~The training program will be developed with the own body weight of each participant. Therefore, a progression according to the needs of this population will be fulfilled. The session model could be multi-joint exercises with self-loads, where the difficulty of the exercises will be worked progressively. Throughout the main part of each workout, 30 seconds of work will be performed at the corresponding intensity and 30 seconds of rest. Halfway through the total repetitions, there will be 2 minutes of recovery.
Study NCT05642169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT+PA
Description: In relation to the 2 groups that will perform HIIT, the HIIT+AF will have to complete 10.000 steps per day. In this way, they will be focusing on increasing their daily physical activity. In addition, this group will perform the same HIIT training programme as the other experimental group.
Study NCT05642169 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: CON
Description: This group will not suffer any changes in their lifestyle
Study NCT06640686 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: Inspiratory muscle training for increase strength of inspiratory muscle.
Study NCT05330572 — intervention group
Intervention type: OTHER
Intervention: No interventions were administered to the patients as a part of this study.
Description: No interventions were administered to the patients as a part of this study. Patients who were under topical steroid regime as a part of their management plan for lichen planus will be enrolled on the study. Details of prescribed topical steroid regime for lichen planus: type of corticosteroid, formulation, frequency of application, duration of treatment will be recorded.
Study NCT05165407 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab 200mg will be intravenously administered on Day 1 of each cycle
Study NCT05165407 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI310
Description: IBI310 1mg/kg be intravenously administered on Day 1 of every 2 cycle
Study NCT05165407 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Surufatinib
Description: Surufatinib 250mg will be taken orally once daily continuously
Study NCT04531839 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Evidence-based collaborative quality improvement
Description: Evidence-based collaborative quality improvement interventions including benchmarking, potential better practice list, PDSA implementation and collaborative learning
Study NCT04609761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Privigen Injectable Product (Intravenous Immunoglobulin)
Description: Privigen, 2 g/kg BW every 4th week for 6 months (= 6 infusions).
Study NCT06463405 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Splinted
Description: The investigators will compare splinted versus non-splinted crowns in a randomized design. Whether the crowns will be splinted or not are decided by distant randomization separate from clinicians conducting the trial. Twenty sealed envelopes will be opened where its stands whether the crowns has to be splinted crowns or non-splinted crowns. The implants in the splinted side will have an intermediate titanium abutment and impression will be taken at abutment level, whereas impressions in the non-splinted side will be taken directly at the fixture level. The splinted as well as the non-splinted crowns will be screw-retained and produced in monolithic zirconia. An open-tray technique / (scanning) will be used for both reconstructions.
Study NCT06362070 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DaVinci® Surgical System
Description: Assisted-robotic radical Gastrectomy
Study NCT06362070 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hugo™ RAS System
Description: Assisted-robotic radical Gastrectomy
Study NCT06362070 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Versius® Robotic Surgery System
Description: Assisted-robotic radical Gastrectomy
Study NCT05303363 — intervention group
Intervention type: DEVICE
Intervention: VV-ECMO
Description: VV-ECMO is indicated in case of severe respiratory failure refractory to other therapies. Indications for VV-ECMO include severe pneumonia, acute respiratory distress syndrome (ARDS) (a.o. due to COVID-19) or near-drowning. ECMO is considered a 'last resort' therapy, in which other maneuvers - such as prone positioning and neuromuscular blockage - have shown to be insufficient. Patients are generally receiving invasive mechanical ventilation and are almost always unconscious, since due to the severe respiratory failure, high doses of sedatives and neuromuscular blockage are often applied to prevent further ventilator-induced damage. After the decision for VV-ECMO is made, the patient is directly cannulated in the ICU or OR following standard protocols.
Study NCT05515315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Participants will receive Tislelizumab, 200mg, intravenously over 30 - 60 minutes, day 1 of every 3 weeks
Study NCT05515315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin paclitaxel
Description: Participants will receive Albumin paclitaxel 260 mg/m2 , day 1 of every 3 weeks
Study NCT05515315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nedaplatin
Description: Participants will receive Nedaplatin 80 mg/m2 , day 1 of every 3 weeks
Study NCT05515315 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: 50-60Gy/25-30f
Study NCT05338242 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real-Time Exposure Feedback
Description: Participants will receive real-time exposure monitors that continuously display real-time air concentration information and a color-coded designation for the current risk level.
Study NCT04410042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: Given IV
Study NCT06640686 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: Inspiratory muscle training for increase strength of inspiratory muscle.
Study NCT06642285 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non Invasive Respiratory Support bundle
Description: premature neonates who will receive evidence-based guidelines for prevention of nasal pressure injuries associated with non invasive respiratory support till weaning
Study NCT06640205 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pulpotomy
Description: Removal of coronal pulp tissue and then placing pulpotomy agent
Study NCT06640205 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pulpotomy
Description: Removal of coronal pulp tissue and then placing pulpotomy agent
Study NCT06638554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Choice
Description: The participant will be send a letter inviting them to complete a SDM visit either in-person or via telehealth.
Study NCT06638554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telehealth Only
Description: The participant will be send a letter inviting them to complete a SDM visit via telehealth only.
Study NCT06638554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Touch Strategy
Description: Patient will be sent asynchronous text messaging reminders encouraging SDM for LCS using framed messaging.
Study NCT06638554 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Touch Strategy
Description: Patient will be sent asynchronous text messaging reminders encouraging SDM for LCS using framed messaging in combination with synchronous telephone-based digital care coordination.
Study NCT06641960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: In this group, the patients will undergo orthodontic treatment with metallic appliances and receive oral hygiene instruction with probiotic lozenges.
Study NCT06641960 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional treatment
Description: In this group, the patients will undergo orthodontic treatment with metallic appliances and receive oral hygiene instruction without probiotic lozenges.
Study NCT06638827 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Sympathectomy
Description: Bilateral thoracoscopic sympathectomy will be performed with general anesthesia, using single lung ventilation and monopolar cautery for transection of the sympathetic chain.~Persons with PFH who underwent the BTS were classified into three groups, depending the level of transaction of sympathetic chain:~1. transection at the level from the second to the forth thoracic sympathetic ganglion (T2- T4);~2. transection at the level from the third to the forth thoracic sympathetic ganglion (T3-T4)~3. transection at the level from the second to the third thoracic sympathetic ganglion (T2-T3)..
Study NCT06637696 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blood Culture Bundle
Description: In this pre and post intervention study investigators aimed to evaluate the impact of a blood culture bundles on the incidence of blood culture contamination rates in NICU.
Study NCT06637696 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Blood Culture Bundle
Description: In this pre and post intervention study investigators aimed to evaluate the impact of a blood culture bundles on the incidence of blood culture contamination rates in NICU.
Study NCT06638047 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: robotic-assisted TKA
Description: Robotic-assisted TKA means that TKA surgery is operated with the guidance of robotic system.
Study NCT06638047 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CI-TKA
Description: TKA operated with conventional instruments
Study NCT06645379 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP) Injections
Description: Transvaginal or laparoscopic injection for ovarian diseases (Premature ovarian insufficiency and Poor ovarian response). Intrauterine perfusion or sub-endometrium injection for uterine diseases (intrauterine adhesion, thin endometrium, and repeated implantation failure)
Study NCT05467826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Velpatasvir + Ribavirin
Description: Sofosbuvir 400mg/velpatasvir 100mg + ribavirin 1000mg/1200mg for 12 weeks
Study NCT05467826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Velpatasvir/Voxilaprevir
Description: Sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg for 12 weeks
Study NCT04174573 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GTO
Description: 1. Forward direction activity: Balance activity in forward direction on wooden balance board (5 reps X 3 sets X 2 days in a week, for 6 weeks)~2. Backward direction activity: Balance activity in backward direction on wooden balance board (5 reps X 3 sets X 2 days in a week, for 6 weeks)~3. Sideways direction activity: Balance activity in sideways direction on wooden balance board (5 reps X 3 sets X 2 days in a week, for 6 weeks)
Study NCT04410042 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% sodium chloride
Description: Given IV
Study NCT06644001 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans GBI-30,6086 (BC GBI-30)
Description: 2g powder/sachet, consists of bacillus coagulans at a dose of 1x10\^9 CFU, taken once daily before a meal.
Study NCT06644001 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2g powder/sachet, consists of maltodextrin only, taken once daily before a meal.
Study NCT04886856 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Moms
Description: Twelve 75 minutes weekly group sessions involving gentle yoga practices designed for pregnant women, led by experienced yoga teachers.
Study NCT04886856 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prenatal Education
Description: Twelve 75 minutes weekly group sessions involving prenatal education (for example, what to expect during your pregnancy, during labor and delivery, and after the delivery of your child).
Study NCT06571331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: De-Stress & Snooze Gummies-U001
Description: Two gummies daily in sequence 30-45 minutes before bed for 60 days
Study NCT06571331 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: De-Stress & Snooze Gummies-I001
Description: Two gummies daily in sequence 30-45 minutes before bed for 60 days
Study NCT06571331 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Gummies 002
Description: Two gummies daily in sequence 30-45 minutes before bed for 60 days